• Profile
Close

Medical use of long-term extended-release opioid analgesics in commercially insured adults in the United States

Pain Medicine Apr 11, 2020

Young JC, et al. - Researchers investigated the proportion of patients initiating extended-release (ER) opioids who become long-term users. Further, they sought to inscribe how pain-related diagnoses before initiation of opioid therapy vary between drugs and over time. Pain-related diagnoses were examined in the 182-day baseline period before initiation of ER opioid therapy using MarketScan (2006–2015), a US national commercial insurance database. They identified 1,077,566 adults initiating ER opioids. Of these, 31% became long-term users, with a median length of use of 209 days. In this national sample of adults with private insurance, oxycodone (26%) and fentanyl (23%) were the most common ER opioids prescribed, and back pain (65%) and arthritis (48%) were the most common noncancer pain diagnoses. Opioids that have been approved within the last 10 years were noted to have more frequent association with musculoskeletal pains and less frequent association with cancer. The findings present context concerning the conditions for which long-term opioid therapy is prescribed, amid increasing concerns regarding long-term opioid therapy.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay